FDA Inspection 958591 — Aptar Pharma Services, Inc.
The FDA completed an inspection of Aptar Pharma Services, Inc. on Jan 26, 2016 in Boonton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 26, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Boonton, NJ (United States)